METHOD FOR DETERMINATION OF HUMAN EMBRYO IMPLANTATION INTO UTERINE MUCOUS MEMBRANE, DEPENDING ON CONTENT OF ACTIVE RECEPTORS TO ESTROGENES IN CHORION AT CYTOMEGALOVIRUS INFECTION EXACERBATION AT FIRST TRIMESTER OF GESTATION Russian patent published in 2017 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: titer of IgG antibody to CMV is determined on weeks 7-8 of gestation, and the content of active receptors for estrogen (ERα) in the chorion homogenate is determined, and when the titer of IgG antibodies to the cytomegalovirus is upto 1:1600, the ERα content in the chorion homogenate is reduced to 3.62±0.51 nmol/l, the threat of impaired embryo implantation into the uterine mucosa is determined, which can lead to its death in the form of spontaneous abortion.

EFFECT: increased accuracy of determination.

1 ex